Francisco Salva
Vorstandsvorsitzender bei AZITRA, INC.
Vermögen: 74 426 $ am 30.04.2024
Profil
Mr. Francisco D.
Salva is a President, Chief Executive Officer & Director at Azitra, Inc. and an Independent Director at Vincerx Pharma, Inc. He is on the Board of Directors at Azitra, Inc. and Vincerx Pharma, Inc. Mr. Salva was previously employed as a President, Chief Executive Officer & Director by Complexa, Inc., an Operating Partner by Accelerator Services Corp, a Vice President-Operations by Acerta Pharma BV, and a Senior Director-Corporate Finance by Pharmacyclics LLC.
He received his undergraduate degree from Brown University and a graduate degree from London School of Economics & Political Science.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AZITRA INC
1,17% | 13.02.2024 | 338 300 ( 1,17% ) | 74 426 $ | 30.04.2024 |
VINCERX PHARMA INC
-.--% | 26.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Francisco Salva
| Unternehmen | Position | Beginn |
|---|---|---|
| VINCERX PHARMA, INC. | Direktor/Vorstandsmitglied | 23.12.2020 |
| AZITRA, INC. | Vorstandsvorsitzender | 04.05.2021 |
Ehemalige bekannte Positionen von Francisco Salva
| Unternehmen | Position | Ende |
|---|---|---|
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Vorstandsvorsitzender | 01.08.2020 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Gründer | 01.11.2016 |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Corporate Officer/Principal | - |
| PHARMACYCLICS, INC. | Finanzdirektor/CFO | - |
Ausbildung von Francisco Salva
| Brown University | Undergraduate Degree |
| London School of Economics & Political Science | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
| Azitra, Inc. | |
| Vincerx Pharma, Inc. |
